Skip to content
DraconiticResearch
Search Sources API
197,785 studies31 sourcesUpdated 12 min ago
Peer-reviewedCC BY-NC-NDBMC medicine

Voxel-based texture similarity networks reveal abnormal brain network topology linked to molecular signatures in amyotrophic lateral sclerosis.

7 affiliations
  1. 1Department of Radiology, Fujian Medical University Union Hospital, Fuzhou, 350001, China.
  2. 2Department of Radiology, Tianjin Key Lab of Functional Imaging & Tianjin Institute of Radiology, Tianjin Medical University General Hospital, Tianjin, 300052, China.
  3. 3Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, 350001, China. [email protected].
  4. 4Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, 350001, China. [email protected].
  5. 5Department of Radiology, Tianjin Key Lab of Functional Imaging & Tianjin Institute of Radiology, Tianjin Medical University General Hospital, Tianjin, 300052, China. [email protected].
  6. 6Department of Radiology, Tianjin Key Lab of Functional Imaging & Tianjin Institute of Radiology, Tianjin Medical University General Hospital, Tianjin, 300052, China. [email protected].
  7. 7Department of Radiology, Fujian Medical University Union Hospital, Fuzhou, 350001, China. [email protected].

Abstract

Background

While amyotrophic lateral sclerosis (ALS) is characterized by disrupted brain network function, the abnormal patterns of structural similarity networks and their biological underpinnings remain poorly understood. This study employed voxel-based texture similarity network (vTSN) analysis to identify complex brain network disruptions in ALS, aiming to advance the pathophysiological understanding of the disease.Methods

Individual vTSNs were constructed based on structural T1-weighted magnetic resonance imaging data from 113 patients with ALS and 144 healthy controls. We first explored the vTSN disruption patterns in ALS patients and compared their sensitivity with two other popular structural similarity networks: morphometric similarity networks (MSN) and morphometric inverse divergence (MIND). We then linked vTSN abnormalities with molecular signatures. Finally, we explored the potential of vTSN in predicting the clinical traits and states of ALS patients.Results

ALS patients demonstrated bidirectional patterns of both increased and decreased connectivity in vTSN (P < 0.05, Bonferroni correction), particularly involving sensorimotor network (SMN), default mode network (DMN), frontoparietal network (FPN) and subcortical network (SN). vTSN showed the highest sensitivity in detecting abnormal connectivity (N = 137) compared to the two well-known approaches, MSN (N = 0) and MIND (N = 30) (P < 0.05, Bonferroni correction), and revealed unique disruption patterns (r < 0.02, P > 0.05). Notably, vTSN alterations were linked to ALS risk genes; representative genes CHMP2B and SOD1 showed distinct developmental profiles and significant regional correlations. Furthermore, vTSN changes mirrored neuroreceptor distributions (notably M1, 5-HT6, and MOR), with M1 showing coupling in the SN and FPN, linking network decay to neurochemical imbalances. Finally, the network-based vTSN model achieved robust diagnostic power (AUC = 0.757), which was statistically equivalent to edge-level or whole-brain models (DeLong's test, P > 0.05).Conclusions

vTSN exhibits excellent performance for detecting network abnormality in ALS and reveals potential molecular signatures of the pathophysiology of disease. These findings underscore the potential of vTSN-derived network measure as a biologically meaningful biomarker for ALS.

Related

  1. OGT regulates RNA-binding protein nucleocytoplasmic partitioning, but this fails in amyotrophic lateral sclerosis
    Yiran Wang, Lisa Fournier, Benjamin Wymann +3
    iSciencePeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationCell biologyCell PressCrossrefEurope PMC
  2. Sex-dependent DNA methylation in amyotrophic lateral sclerosis
    Y. J. Kim, A. Iacoangeli, R. A. J. Zwamborn +26
    bioRxivPreprintAll rights reservedFull textGenetics & genomicsbioRxiv
  3. ARPP21 defines a TDP-43-independent aggregation pathway in amyotrophic lateral sclerosis
    D. Campos-Melo, A. A. Dilliott, S. M. K. Farhan +2
    bioRxivPreprintCC BYFull textNeurosciencebioRxiv
  4. NEK1 autophosphorylation is disrupted by amyotrophic lateral sclerosis-associated missense variants: activity biomarkers and structural insights
    S. Agarwal, S. A. Abdul Rehman, I. M. Munoz +10
    bioRxivPreprintCC BYFull textNeurosciencebioRxiv
  5. Familial, neuropathological and cellular analysis identify ARPP21 as a major amyotrophic lateral sclerosis associated gene in French cohorts
    Sibylle de Bertier, Maria-Del-Mar Amador, Claire Guissart +19
    Acta NeuropathologicaPeer-reviewedCC BY-NC-ND 4.0Full textGenetics & genomicsNeuroscienceHALHAL
BibTeX
@article{zhuang2026voxelbased,
  title = {{Voxel-based texture similarity networks reveal abnormal brain network topology linked to molecular signatures in amyotrophic lateral sclerosis.}},
  author = {Shao-Peng Zhuang and Zi-Wei Cai and Zhe-Yi Huang and Li-Yuan Lin and Sheng Chen and Zhang-Yu Zou and Hao Ding and Wen Qin and Hua-Jun Chen},
  journal = {BMC medicine},
  year = {2026},
  month = aug,
  doi = {10.1186/s12916-026-05111-4},
  url = {https://europepmc.org/article/MED/42972546},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Voxel-based texture similarity networks reveal abnormal brain network topology linked to molecular signatures in amyotrophic lateral sclerosis.
AU  - Shao-Peng Zhuang
AU  - Zi-Wei Cai
AU  - Zhe-Yi Huang
AU  - Li-Yuan Lin
AU  - Sheng Chen
AU  - Zhang-Yu Zou
AU  - Hao Ding
AU  - Wen Qin
AU  - Hua-Jun Chen
PY  - 2026
DA  - 2026/08/03
JO  - BMC medicine
DO  - 10.1186/s12916-026-05111-4
UR  - https://europepmc.org/article/MED/42972546
AB  - Background  While amyotrophic lateral sclerosis (ALS) is characterized by disrupted brain network function, the abnormal patterns of structural similarity networks and their biological underpinnings remain poorly understood. This study employed voxel-based texture similarity network (vTSN) analysis to identify complex brain network disruptions in ALS, aiming to advance the pathophysiological understanding of the disease.Methods  Individual vTSNs were constructed based on structural T1-weighted magnetic resonance imaging data from 113 patients with ALS and 144 healthy controls. We first explored the vTSN disruption patterns in ALS patients and compared their sensitivity with two other popular structural similarity networks: morphometric similarity networks (MSN) and morphometric inverse divergence (MIND). We then linked vTSN abnormalities with molecular signatures. Finally, we explored the potential of vTSN in predicting the clinical traits and states of ALS patients.Results  ALS patients demonstrated bidirectional patterns of both increased and decreased connectivity in vTSN (P < 0.05, Bonferroni correction), particularly involving sensorimotor network (SMN), default mode network (DMN), frontoparietal network (FPN) and subcortical network (SN). vTSN showed the highest sensitivity in detecting abnormal connectivity (N = 137) compared to the two well-known approaches, MSN (N = 0) and MIND (N = 30) (P < 0.05, Bonferroni correction), and revealed unique disruption patterns (r < 0.02, P > 0.05). Notably, vTSN alterations were linked to ALS risk genes; representative genes CHMP2B and SOD1 showed distinct developmental profiles and significant regional correlations. Furthermore, vTSN changes mirrored neuroreceptor distributions (notably M1, 5-HT6, and MOR), with M1 showing coupling in the SN and FPN, linking network decay to neurochemical imbalances. Finally, the network-based vTSN model achieved robust diagnostic power (AUC = 0.757), which was statistically equivalent to edge-level or whole-brain models (DeLong's test, P > 0.05).Conclusions  vTSN exhibits excellent performance for detecting network abnormality in ALS and reveals potential molecular signatures of the pathophysiology of disease. These findings underscore the potential of vTSN-derived network measure as a biologically meaningful biomarker for ALS.
SN  - 1741-7015
ER  -